Chris Adams

Mr. Adams has been a founder or co-founder of life science and technology based companies in Massachusetts for the past several years. From new obesity therapeutics to software to detect eye disease. Mr. Adams contributed genomics technology to the development of Cologuard, a colon cancer detection test. Mr. Adams has also developed a cornea wound treatment technology that is the current standard of care. Collectively, the technologies have been used on over 4 million patients to date.